Boston Scientific Corp
(MIL:1BSX)
€
85.5
0 (0%)
Market Cap: 126.98 Bil
Enterprise Value: 135.61 Bil
PE Ratio: 74.26
PB Ratio: 6.39
GF Score: 56/100 Boston Scientific Corp at Sanford C Bernstein Strategic Decisions Conference (Virtual) Transcript
Jun 04, 2021 / 12:00PM GMT
Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst
All right. Good morning, everybody. Thank you for joining. I'm Lee Hambright, U.S. Medical Device analyst at Bernstein. We are thrilled to host Mike Mahoney from Boston Scientific this morning. We're scheduled for a 50-minute fireside chat here. (Operator Instructions)
So Mike, first of all, thanks so much for joining. Really appreciate the time today.
Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO
Pleasure, Lee. Can you hear me okay?
Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst
Can hear you fine. Thank you.
So let's kick off. It's been a wild ride, of course, for all of us over the last 16 or 17 months. But Boston Scientific is off to a good start in 2021. You delivered a nice, clean beat and raise in the first quarter. Your stock's outperforming large-cap medtech.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot